Alitair Pharmaceuticals, Inc. — Form D
Alitair Pharmaceuticals, Inc. of MORRISTOWN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-09. The offering totals $32.0M, of which $115K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-10-09
- Form: D
- Accession: 0001144204-18-052993
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $115K
- Remaining: $31.9M
- Minimum investment: $5K
- Investors: 3
- Date of first sale: 2018-09-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-323114
Issuer
- Name: Alitair Pharmaceuticals, Inc.
- CIK: 0001654448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 55 MADISON STREET, MORRISTOWN, NJ, 07960
- Phone: 973-984-1669
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Frank E Guarino | Executive Officer | Morristown, NJ |
| Robert E Casale | Director | Morristown, NJ |
| James E Hoyes | Director | Morristown, NJ |
| James E Hoyes | Executive Officer | Morristown, NJ |
| William W Howard | Director | Morristown, NJ |
| William W Howard | Executive Officer | Morristown, NJ |
Other filings by this issuer (4)
More